7148 DPHARMA | Malaysia
DUOPHARMA BIOTECH BERHAD
RM 2.85 on: 2021-07-23
-0.35% Past 1-day return
-1.72% Past 5-day return
Price/Valuation Analysis
Current Price Status
-
Stock is in Momentum
Stock is currently overvalued by the market with the expectation of annual earning growth at 44.01% to match current price.
Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation. -
Company is in Positive Earning
Fair Value
- DPHARMA current price is 12.2% above OneDelta estimated fair value.
-
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
-
Underperformed
DPHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 1.64% -
Below 30-Day Average
Current price RM2.85 is below 30-day average RM3.01 by 5.6%
| Return (%) | DPHARMA | Pharmaceuticals |
|---|---|---|
| 1-Day | -0.35% | -0.36% |
| 5-Day | -1.72% | -0.08% |
| 30-Day | -10.09% | -12.25% |
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
-
Cyclical Revenue Growth
DPHARMA recorded various revenue growth in different quarters with no clear growth direction.
-
Unstable Profit Growth
DPHARMA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
| Quarter Date | Revenue (RM) | (%) | EPS (RM) | (%) |
|---|---|---|---|---|
| 2020-12-31 | 134,086k | +0% | 0.0229 | +13% |
| 2020-09-30 | 133,772k | -7% | 0.0203 | -6% |
| 2020-06-30 | 143,331k | -10% | 0.0215 | +9% |
| 2020-03-31 | 158,713k | +15% | 0.0198 | +13% |
| 2019-12-31 | 137,755k | -4% | 0.0176 | -20% |
Volume Trend Analysis
-
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
-
DPHARMA recent daily traded volume is -25% lower than past month average.
| Past 30-Day | Past 5-Day |
|---|---|
| 16k daily | 12k daily |
Financials
Price History Chart
Past 30-day Average Price: RM3.01
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
Healthy outlook for Duopharma Biotech
Duopharma rises on strong earnings
Duopharma says 1Q net profit rises 30% on higher sales, proposes bonus issue
Duopharma posts higher Q1 net profit, vaccine deal to boost FY21 earnings
Duopharma earnings soar, plans bonus issue
CGS-CIMB Research upgrades Duopharma to add, TP RM3.67
Duopharma's bullish momentum to continue
Duopharma posts stronger 4Q net profit, div 6c
Duopharma to supply 6.4 million doses of Sputnix V vaccine
Duopharma signs deal with Putrajaya to supply Russian Covid-19 vaccine
Stock Company Profile
DUOPHARMA BIOTECH BERHAD
Duopharma Biotech Bhd. is an investment holding company, which engages in the research, development, and commercialization of chemical and pharmaceutical products. Its products include tablets, capsules, syrup, antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectibles, small volume injectibles, dental cartridges, and eye drop preparations. The company was founded in 1979 and is headquartered in Klang, Malaysia.